Northwell Health Rankings: 4 Hospitals Rated Among Nation’s Best in 2021-22 US News & World Report Rankings

Northwell Health Rankings: Four Northwell Health hospitals received top-50 national ratings in 22 adult medical specialties – including three among the top 20 – in US News & World Report’s 2021-22 Best Hospital rankings.

Three of those hospitals – Lenox Hill Hospital in Manhattan, North Shore University Hospital in Manhasset and Long Island Jewish Medical Center in New Hyde Park – rate among the top 7 hospitals in the New York metropolitan area and the entire state, according to US News’ analysis of more than 4,500 medical centers nationwide.

Northwell Health, New York State’s largest health system and private employer, played a leading role throughout the coronavirus disease 2019 (COVID-19) pandemic, from providing diagnostic testing to delivering vaccines and nursing the sick. The health system treated more COVID-19 patients than any other, collaborated with local, state and federal agencies to tramp down the virus and extended its outreach to underserved populations throughout its geographic footprint across Long Island, New York City and Westchester.

“Northwell Health’s patient-centric culture, along with the collaboration our staff displays each day, is not only reflected in these impressive rankings, but in the fact that we helped New Yorkers get through the worst health care crisis in a century,” said Michael J. Dowling, president and chief executive officer of Northwell Health. “I am extremely proud of our hospital leadership, physicians, nurses and all of our caregivers for their dedication, compassion and expertise.”

Lenox Hill Hospital, the fourth-ranked medical center in the state and New York Metro region, achieved top-50 national ratings in seven medical specialties: neurology and neurosurgery (23rd best in the nation), orthopedics (25th), ear, nose and throat (27th), cardiology and heart surgery (28th), gynecology (31st), diabetes and endocrinology (38th) and geriatrics (39th).

North Shore University Hospital (NSUH) ranked fifth in the metro area and state and is Long Island’s top hospital, according to US News. The hospital was nationally recognized in eight specialties: pulmonology (17th), cardiology and heart surgery (21st), orthopedics (24th), urology (25th), geriatrics (29th), diabetes and endocrinology (31st), gastroenterology (GI) and GI surgery (39th) and neurology and neurosurgery (46th).

Long Island Jewish (LIJ) Medical Center ranked seventh (tied) in the metro area and state and was nationally recognized in five specialties: gynecology (15th), neurology and neurosurgery (20th), urology (22nd), ear, nose and throat (40th), and geriatrics (47th).

Huntington Hospital was ranked 10th-best in the state and 12th in the region, and its orthopedics (44th) program achieved national status once again with pulmonology and lung surgery jumping to 47th.

US News conducts a separate analysis of the nation’s best children’s hospitals. In the latest survey results released on June 15, Northwell’s Cohen Children’s Medical Center in New Hyde Park was ranked No. 1 in New York State and earned top 50 national rankings for exceptional care in nine pediatric specialties. The largest provider of pediatric health services in New York State, Cohen Children’s has been ranked among the nation’s top children’s hospitals by US News for 15 consecutive years.

This marks the 32nd edition of US News’ Best Hospitals rankings. Its methodologies in most areas of care are based largely on objective measures such as risk-adjusted survival and discharge-to-home rates, volume, and quality of nursing, among other care-related indicators. US News evaluated nearly 5,000 medical centers nationwide in 15 specialties, procedures and conditions to compile its 2021-22 rankings. Only 175 U.S. hospitals were ranked in at least one specialty.

For a complete listing of US News’ Best Hospitals rankings, go to: Best Hospitals.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”